For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs ...
SGLT2 inhibitors were associated with better cardioprotective effects among older adults than younger adults with type 2 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback